Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma

International Journal of Pharmaceutics

Volumn 474, Issue 1-2, 2014, Pages 223-231

  Xie, Meng ^a   Xu, Yuanguo ^a   Shen, Haijun ^a   Shen, Song ^a   Ge, Yanru ^a   Xie, Jimin ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Antitumor; Biodistribution; Doxorubicin; Liver tumor in situ; Mesoporous silica nanoparticles; Survival rate

Indexed keywords

DOXORUBICIN; MESOPOROUS SILICA NANOPARTICLE; NANOCARRIER; NANOPARTICLE; SILICON DIOXIDE; UNCLASSIFIED DRUG; DRUG VEHICLE; DRUG CARRIER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARCINOMA CELL; CARDIOTOXICITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; DRUG SAFETY; ENDOCYTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOLECULARLY TARGETED THERAPY; MOUSE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; ZETA POTENTIAL; CANCER INHIBITION; DRUG EFFICACY; HEPG2 CELL LINE; LIVER CELL DAMAGE; PARTICLE SIZE; SURVIVAL TIME; ANIMAL; CARCINOMA, HEPATOCELLULAR; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER NEOPLASMS; METABOLISM; NEOPLASMS, EXPERIMENTAL; NUDE MOUSE; PATHOLOGY; POROSITY; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY; TISSUE DISTRIBUTION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED ICR; MICE, NUDE; NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; POROSITY; SILICON DIOXIDE; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 84906724779     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.08.027     Document Type: Article

References (46)

1. A. Al-Nahain, S.Y. Lee, I. In, K.D. Lee, and S.Y. Park Triggered pH/redox responsive release of doxorubicin from prepared highly stable graphene with thiol grafted Pluronic Int. J. Pharm. 450 2013 208 217
2. L.M. Alexander, S. Pernagallo, A. Livigni, R.M. Sanchez-MartIn, J.M. Brickman, and M. Bradley Investigation of microsphere-mediated cellular delivery by chemical: microscopic and gene expression analysis Mol. Biosyst. 6 2010 399 409
3. F. Alexis, E. Pridgen, L.K. Molnar, and O.C. Farokhzad Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharm. 5 2008 505 515
4. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 2004 1818 1822 (Pubitemid 38374867)
5. M. Amin, A. Badiee, and M.R. Jaafari Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas Int. J. Pharm. 458 2013 324 333
6. A. Cambón, A. Rey-Rico, D. Mistry, J. Brea, M.I. Loza, D. Attwood, S. Barbosa, C. Alvarez-Lorenzo, A. Concheiro, P. Taboada, and V. Mosquera Doxorubicin-loaded micelles of reverse poly(butylene oxide)-poly(ethylene oxide)-poly(butylene oxide) block copolymers as efficient active chemotherapeutic agents Int. J. Pharm. 445 2013 47 57
7. N. Cao, and S.S. Feng Doxorubicin conjugated to d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation Biomaterials 29 2008 3856 3865
8. Y. Chen, W. Yang, B. Chang, H. Hu, X. Fang, and X. Sha In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide- co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation Eur. J. Pharm. Biopharm. 85 2013 406 412
9. Y. Chen, H. Chen, and J. Shi Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures RSC Adv. 11 2014 917 930
10. G. Cirillo, O. Vittorio, S. Hampel, U.G. Spizzirri, N. Picci, and F. Iemma Incorporation of carbon nanotubes into a gelatin-catechin conjugate: innovative approach for the preparation of anticancer materials Int. J. Pharm. 446 2013 176 182
11. F. Danhier, O. Feron, and V. Préat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control Release 148 2010 135 146
12. H.H. Duong, and L.Y. Yung Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment Int. J. Pharm. 454 2013 486 495
13. A. Elsayed, M. Al-Remawi, I. Maghrabi, M. Hamaidi, and N. Jaber Development of insulin loaded mesoporous silica injectable particles layered by chitosan as a controlled release delivery system Int. J. Pharm. 461 2014 448 458
14. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN Int. J. Cancer 127 2010 2893 2917
15. J.M. Gao, F. Qian, A. Szymanski-Exner, N. Stowe, and J. Haaga In vivo drug distribution dynamics in thermoablated and normal rabbit livers from biodegradable polymers J. Biomed. Mater. Res. 62 2002 308 314 (Pubitemid 34988509)
16. H. Guo, Q. Lai, W. Wang, Y. Wu, C. Zhang, Y. Liu, and Z. Yuan Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy Int. J. Pharm. 451 2013 1 11
17. H. Guo, D. Zhang, C. Li, L. Jia, G. Liu, L. Hao, D. Zheng, J. Shen, T. Li, Y. Guo, and Q. Zhang Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin Int. J. Pharm. 458 2013 31 38
18. T. Hirai, Y. Korogi, K. Ono, K. Maruoka, K. Harada, S. Aridomi, and M. Takahashi Intra-arterial chemotherapy or chemoembolization for locally advanced and/or recurrent hepatic tumors: evaluation of the feeding artery with an interventional CT system Cardiovasc. Intervent. Radiol. 24 2001 176 179 (Pubitemid 32587871)
19. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
20. L. Jia, J. Shen, Z. Li, D. Zhang, Q. Zhang, G. Liu, D. Zheng, and X. Tian In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes Int. J. Pharm. 445 2013 12 19
21. D. Kim, Z.G. Gao, E.S. Lee, and Y.H. Bae In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer Mol. Pharm. 6 2009 1353 1362
22. S.D. Li, and L. Huang Pharmacokinetics and biodistribution of nanoparticles Mol. Pharm. 5 2008 496 504
23. J.H. Maeng, D.H. Lee, K.H. Jung, Y.H. Bae, I.S. Park, S. Jeong, Y.S. Jeon, C.K. Shim, W. Kim, J. Kim, J. Lee, Y.M. Lee, J.H. Kim, W.H. Kim, and S.S. Hong Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemo-therapy and magnetic resonance imaging in liver cancer Biomaterials 31 2010 4995 5006
24. V. Mamaeva, C. Sahlgren, and M. Linden Mesoporous silica nanoparticles in medicine-recent advances Adv. Drug Deliv. Rev. 65 2013 689 702
25. L. Minati, V. Antonini, S. Torrengo, M.D. Serra, M. Boustta, X. Leclercq, C. Migliaresi, M. Vert, and G. Speranza Sustained in vitro release and cell uptake of doxorubicin adsorbed onto gold nanoparticles and covered by a polyelectrolyte complex layer Int. J. Pharm. 438 2012 45 52
26. P. Nadrah, O. Planinsek, and M. Gaberscek Stimulus-responsive mesoporous silica particles J. Mater. Sci. 49 2014 481 495
27. H. Peng, R. Dong, S. Wang, Z. Zhang, M. Luo, C. Bai, Q. Zhao, J. Li, L. Chen, and H. Xiong A pH-responsive nano-carrier with mesoporous silica nanoparticles cores and poly(acrylic acid) shell-layers: fabrication characterization and properties for controlled release of salidroside Int. J. Pharm. 446 2013 153 159
28. L. Philosof-Mazor, G.R. Dakwar, M. Popov, S. Kolusheva, A. Shames, C. Linder, S. Greenberg, E. Heldman, D. Stepensky, and R. Jelinek Bolaamphiphilic vesicles encapsulating iron oxide nanoparticles: new vehicles for magnetically targeted drug delivery Int. J. Pharm. 450 2013 241 249
29. S.R. Popielarski, S. Hu-Lieskovan, S.W. French, T.J. Triche, and M.E. Davis A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver: 2. In vitro and in vivo uptake results Bioconjug. Chem. 16 2005 1071 1080 (Pubitemid 41368107)
30. L.Y. Qiu, L. Yan, L. Zhang, Y.M. Jin, and Q.H. Zhao Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery Int. J. Pharm. 456 2013 315 324
31. N. Schleich, P. Sibret, P. Danhier, B. Ucakar, S. Laurent, R.N. Muller, C. Jérôme, B. Gallez, V. Préat, and F. Danhier Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging Int. J. Pharm. 447 2013 94 101
32. X.R. Song, Y. Zhen g, G. He, L. Yang, Y.F. Luo, Z.Y. He, S.Z. Li, J.M. Li, S. Yu, X. Luo, S.X. Hou, and Y.Q. Wei Development of PLGA nanoparticles simultaneously loaded with vincristine and verapamil for treatment of hepatocellular carcinoma J. Pharm. Sci. 99 2010 4874 4879
33. I. Sugiyama, and Y. Sadzuka Enhanced antitumor activity of different double arms polyethyleneglycol-modified liposomal doxorubicin Int. J. Pharm. 441 2013 279 284
34. Z. Tao Mesoporous silica-based nanodevices for biological applications RSC Adv. 36 2014 18961 18980
35. U. Termsarasab, I.S. Yoon, J.H. Park, H.T. Moon, H.J. Cho, and D.D. Kim Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin Int. J. Pharm. 464 2014 127 134
36. S. Wang, H. Xu, J. Xu, Y. Zhang, Y. Liu, Y.H. Deng, and D. Chen Sustained liver targeting and improved antiproliferative effect of doxorubicin liposomes modified with galactosylated lipid and PEG-lipid AAPS PharmSciTech 11 2010 870 877
37. L.H. Wang, X. Che, H. Xu, L.L. Zhou, J. Han, M.J. Zou, J. Liu, Y. Liu, J.W. Liu, and W. Zhang A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique Int. J. Pharm. 454 2013 135 142
38. K. Xiao, Y.P. Li, J.T. Luo, J.S. Lee, W.W. Xiao, A.M. Gonik, R.G. Agarwal, and K.S. Lam The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles Biomaterials 32 2011 3435 3446
39. Y. Xiao, H. Zhang, Z. Zhang, M. Yan, M. Lei, K. Zeng, and C. Zhao Synthesis of novel tetravalent galactosylated DTPA-DSPE and study on hepatocyte-targeting efficiency in vitro and in vivo Int. J. Nanomedicine 8 2013 3033 3050
40. M. Xie, H. Shi, K. Ma, H. Shen, B. Li, S. Shen, X. Wang, and Y. Jin Hybrid nanoparticles for drug delivery and bioimaging: mesoporous silica nanoparticles functionalized with carboxyl groups and a near-infrared fluorescent dye J. Colloid Interface Sci. 395 2013 306 314
41. M. Xie, H. Shi, Z. Li, H. Shen, K. Ma, B. Li, S. Shen, and Y. Jin A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging Colloids Surf. B 110 2013 138 147
42. J.H. Xu, F.P. Gao, L.L. Li, H.L. Ma, Y.S. Fan, W. Liu, S.S. Guo, X.Z. Zhao, and H. Wang Gelatin-mesoporous silica nanoparticles as matrix metalloproteinases-degradable drug delivery systems in vivo Micropor. Mesopor. Mater. 182 2013 165 172
43. P.P. Yang, S.L. Gai, and J. Lin Functionalized mesoporous silica materials for controlled drug delivery Chem. Soc. Rev. 41 2012 3679 3698
44. X. Yao, J.F. Hu, M. Daniels, H. Yien, H. Lu, H. Sharan, X. Zhou, Z. Zeng, T. Li, Y. Yang, and A.R. Hoffman A novel orthotopic tumor model to study growth factors and oncogenes in hepatocarcinogenesis Clin. Cancer Res. 9 2003 2719 2726 (Pubitemid 36842118)
45. C. Zhang, W. Wang, T. Liu, Y. Wu, H. Guo, P. Wang, Q. Tian, Y. Wang, and Z. Yuan Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy Biomaterials 33 2012 2187 2196
46. Q. Zheng, T. Lin, H. Wu, L. Guo, P. Ye, Y. Hao, Q. Guo, J. Jiang, F. Fu, and G. Chen Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release Int. J. Pharm. 463 2014 22 26